BRCA1 and ovarian carcinoma: A urine test also lends itself to home-based self-sampling with postal return to the laboratory for asymptomatic women at increased risk of ovarian cancer (eg BRCA1/2 pathogenic variant carriers), for whom repeat sampling at regular intervals could be important for early detection.